(28/05/2017)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 40 | 6 | 2 / 2100% | 2 / 633.3% | 0 / 10% | 2 / 728.6% | | 3 | 12 | 6 | 18 | 2 | 0 | 1 | 3 | 19 |
(21/05/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 15 | 1 / 333.3% | 4 / 944.4% | 2 / 2100% | 6 / 1154.5% | | 3 | 6 | 7 | 13 | 3 | 0 | 1 | 2 | 23 |
(14/05/2017)vs
ELNAVI | 00 | 16 | 2 / 366.7% | 4 / 1921.1% | 2 / 728.6% | 6 / 2623.1% | | 1 | 12 | 6 | 18 | 0 | 5 | 1 | 2 | 17 |
(07/05/2017)vs
ΠΗΓΑΣΟΣ | 00 | 8 | 2 / 450% | 3 / 1030% | 0 / 20% | 3 / 1225% | | 4 | 14 | 5 | 19 | 0 | 0 | 1 | 1 | 16 |
(22/04/2017)vs
ΠΟΛΙΤΙΣΤΙΚΟ ΚΕΝΤΡΟ ΕΡΓΑΖΟΜΕΝΩΝ Ε.ΥΔ.ΑΠ. | 00 | 7 | 1 / 1100% | 3 / 560% | 0 / 10% | 3 / 650% | | 4 | 5 | 1 | 6 | 2 | 0 | 0 | 1 | 11 |
(19/03/2017)vs
MINERVA MARINE | 00 | 7 | 2 / 450% | 1 / 520% | 1 / 425% | 2 / 922.2% | | 3 | 16 | 4 | 20 | 2 | 0 | 0 | 1 | 19 |
(11/03/2017)vs
ΚΑΤΣΕΛΗΣ | 00 | 5 | 3 / 3100% | 1 / 333.3% | 0 / 00% | 1 / 333.3% | | 0 | 2 | 2 | 4 | 1 | 0 | 1 | 1 | 8 |
(05/03/2017)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 00 | 8 | 2 / 450% | 3 / 837.5% | 0 / 40% | 3 / 1225% | | 2 | 17 | 3 | 20 | 2 | 2 | 0 | 5 | 16 |
(11/02/2017)vs
ΠΗΓΑΣΟΣ | 00 | 5 | 0 / 00% | 1 / 520% | 1 / 250% | 2 / 728.6% | | 3 | 11 | 2 | 13 | 1 | 1 | 1 | 2 | 14 |
(28/01/2017)vs
ΠΟΛΙΤΙΣΤΙΚΟ ΚΕΝΤΡΟ ΕΡΓΑΖΟΜΕΝΩΝ Ε.ΥΔ.ΑΠ. | 00 | 16 | 2 / 2100% | 7 / 1163.6% | 0 / 20% | 7 / 1353.8% | | 3 | 7 | 3 | 10 | 3 | 1 | 1 | 3 | 22 |
(22/01/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 7 | 1 / 250% | 3 / 742.9% | 0 / 40% | 3 / 1127.3% | | 2 | 10 | 2 | 12 | 0 | 0 | 3 | 1 | 12 |
(18/12/2016)vs
MINERVA MARINE | 22 | 13 | 0 / 40% | 5 / 862.5% | 1 / 425% | 6 / 1250% | | 1 | 7 | 5 | 12 | 2 | 2 | 1 | 3 | 17 |
(11/12/2016)vs
ΚΑΤΣΕΛΗΣ | 00 | 0 | 0 / 00% | 0 / 00% | 0 / 00% | 0 / 00% | | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
(04/12/2016)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 00 | 5 | 1 / 1100% | 2 / 1020% | 0 / 30% | 2 / 1315.4% | | 1 | 11 | 4 | 15 | 1 | 1 | 2 | 4 | 9 |
(27/11/2016)vs
OMS | 00 | 11 | 7 / 887.5% | 2 / 922.2% | 0 / 20% | 2 / 1118.2% | | 2 | 10 | 6 | 16 | 2 | 1 | 1 | 2 | 19 |
(13/11/2016)vs
OMS | 00 | 18 | 0 / 20% | 6 / 1060% | 2 / 633.3% | 8 / 1650% | | 3 | 12 | 8 | 20 | 1 | 1 | 2 | 6 | 26 |
(06/11/2016)vs
PHARMACIA | 22 | 0 | 0 / 00% | 0 / 50% | 0 / 20% | 0 / 70% | | 5 | 5 | 4 | 9 | 1 | 2 | 0 | 3 | 2 |
(16/10/2016)vs
OMS | 00 | 5 | 0 / 00% | 1 / 616.7% | 1 / 333.3% | 2 / 922.2% | | 2 | 10 | 3 | 13 | 1 | 0 | 0 | 5 | 7 |
(09/10/2016)vs
PHARMACIA | 00 | 3 | 1 / 425% | 1 / 714.3% | 0 / 30% | 1 / 1010% | | 0 | 8 | 4 | 12 | 2 | 1 | 1 | 4 | 3 |
(02/10/2016)vs
ΚΑΤΣΕΛΗΣ | 40 | 7 | 5 / 1050% | 1 / 714.3% | 0 / 40% | 1 / 119.1% | | 3 | 16 | 3 | 19 | 0 | 0 | 1 | 0 | 12 |
| ΣΥΝΟΛΙΚΑ |
124 |
162 |
32 / 5756.1% |
50 / 15033.3% |
10 / 5617.9% |
60 / 20629.1% |
|
45 |
191 |
78 |
269 |
26 |
17 |
18 |
49 |
272 |
| ΜΕΣΟΙ ΟΡΟΙ |
6.2 |
8.1 |
1.6 / 2.856.1% |
2.5 / 7.533.3% |
0.5 / 2.817.9% |
3 / 10.329.1% |
|
2.2 |
9.6 |
3.9 |
13.4 |
1.3 |
0.8 |
0.9 |
2.4 |
13.6 |